Get started
Author

Marcin Mikołaj Grzybowski

Observed names: M. Grzybowski, M.M. Grzybowski, MARCIN M. GRZYBOWSKI, Marcin Grzybowski, Marcin M Grzybowski, Marcin M. Grzybowski, Marcin Mikolaj Grzybowski
ORCID: 0000-0002-5197-7538
Observed ORCID: 0000-0002-5197-7538
OpenAlex ID: A5017316574
Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma
2021 · Anna Sosnowska, Justyna Chlebowska-Tuz, et al. · OncoImmunology · 103
Veterinary vaccines against toxoplasmosis
2014 · ELŻBIETA HISZCZYŃSKA-SAWICKA, JUSTYNA M. GATKOWSKA, et al. · Parasitology · 81
A Novel Oral Arginase 1/2 Inhibitor Enhances the Antitumor Effect of PD-1 Inhibition in Murine Experimental Gliomas by Altering the Immunosuppressive Environment
2021 · Paulina Pilanc, Kamil Wojnicki, et al. · Frontiers in Oncology · 74
PDF
Chitinases and Chitinase-Like Proteins as Therapeutic Targets in Inflammatory Diseases, with a Special Focus on Inflammatory Bowel Diseases
2021 · Marzena Mazur, Anna Zielińska, et al. · International Journal of Molecular Sciences · 56
PDF
Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis
2010 · Bozena Dziadek, Justyna Gatkowska, et al. · Vaccine · 56
Toxoplasma gondii: The vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice
2012 · Bozena Dziadek, Justyna Gatkowska, et al. · Experimental Parasitology · 45
Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy
2023 · Bartlomiej Borek, Julita Nowicka, et al. · Molecular Cancer Therapeutics · 44
PDF
OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer
2022 · Marcin Mikołaj Grzybowski, Paulina Seweryna Stańczak, et al. · Cancers · 44
PDF
Potent but transient immunosuppression of T-cells is a general feature of CD71+ erythroid cells
2021 · Tomasz M. Grzywa, Anna Sosnowska, et al. · Communications Biology · 40
PDF
Metabolomic reprogramming of the tumor microenvironment by dual arginase inhibitor OATD-02 boosts anticancer immunity
2025 · Marcin Mikołaj Grzybowski, Yasemin Uçal, et al. · Scientific Reports · 34
PDF
Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins
2015 · Marcin M. Grzybowski, Bożena Dziadek, et al. · Parasitology Research · 30
Synthesis, evaluation and molecular modelling of piceatannol analogues as arginase inhibitors
2020 · J. Muller, B. Cardey, et al. · RSC Medicinal Chemistry · 18
Mucosal vaccination--an old but still vital strategy.
2012 · Henryka Długońska, Marcin Grzybowski · PubMed · 18
Mycobacterium tuberculosis AtsG (Rv0296c), GlmU (Rv1018c) and SahH (Rv3248c) Proteins Function as the Human IL-8-Binding Effectors and Contribute to Pathogen Entry into Human Neutrophils
2016 · Bozena Dziadek, Anna Brzostek, et al. · PLoS ONE · 15
PDF
Novel orally bioavailable piperidine derivatives as extracellular arginase inhibitors developed by a ring expansion
2023 · Anna Gzik, Bartlomiej Borek, et al. · European Journal of Medicinal Chemistry · 13
Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells
2015 · Katarzyna Dzitko, Marcin Mikołaj Grzybowski, et al. · Parasites & Vectors · 13
PDF
Toxoplasma gondii: Cloning, expression and immunoreactivity of recombinant ROP5 and ROP18 antigens
2015 · Marcin M. Grzybowski, Bożena Dziadek, et al. · Experimental Parasitology · 13
Human toxoplasmosis: a comparative evaluation of the diagnostic potential of recombinant Toxoplasma gondii ROP5 and ROP18 antigens
2015 · Marcin M. Grzybowski, Justyna M. Gatkowska, et al. · Journal of Medical Microbiology · 12
Novel dual arginase 1/2 inhibitor OATD-02 (OAT-1746) improves the efficacy of immune checkpoint inhibitors
2017 · M.M. Grzybowski, P.S. Stańczak, et al. · Annals of Oncology · 11
Therapeutic inhibition of USP7 promotes antitumor immune responses
2025 · Angelika Muchowicz, Katarzyna M Głuchowska, et al. · Journal for ImmunoTherapy of Cancer · 10
PDF
The Anti-Inflammatory Effect of Acidic Mammalian Chitinase Inhibitor OAT-177 in DSS-Induced Mouse Model of Colitis
2022 · Marzena Mazur, Jakub Włodarczyk, et al. · International Journal of Molecular Sciences · 10
PDF
Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy
2017 · P.S. Stanczak, M.M. Grzybowski, et al. · Annals of Oncology · 10
Personalized vaccination? II. The role of natural microbiota in a vaccine-induced immunity.
2011 · Henryka Długońska, Marcin Grzybowski · PubMed · 9
Targeting ARG2 as a novel therapeutic approach for cancer
2019 · M.M. Grzybowski, J. Pęczkowicz-Szyszka, et al. · Annals of Oncology · 6
Functional exhaustion of T lymphocytes in chronic toxoplasmosis.
2013 · Henryka Długońska, Marcin M Grzybowski · PubMed · 5
Works count: 96
Citation count: 793
H-index: 14
I10-index: 22
Year
Topic
Type